Procter And Gamble Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PROCTER AND GAMBLE, and what generic and branded alternatives to PROCTER AND GAMBLE drugs are available?
PROCTER AND GAMBLE has three approved drugs.
Drugs and US Patents for Procter And Gamble
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Procter And Gamble | FURADANTIN | nitrofurantoin | TABLET;ORAL | 008693-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Procter And Gamble | SARENIN | saralasin acetate | INJECTABLE;INJECTION | 018009-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Procter And Gamble | FURADANTIN | nitrofurantoin | TABLET;ORAL | 008693-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Procter And Gamble | IVADANTIN | nitrofurantoin sodium | INJECTABLE;INJECTION | 012402-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Procter And Gamble
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Procter And Gamble | SARENIN | saralasin acetate | INJECTABLE;INJECTION | 018009-001 | Approved Prior to Jan 1, 1982 | 3,886,134 | ⤷ Sign Up |
Procter And Gamble | SARENIN | saralasin acetate | INJECTABLE;INJECTION | 018009-001 | Approved Prior to Jan 1, 1982 | 3,932,624 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.